Holding(s) in Company

RNS Number : 2440J

Allergy Therapeutics PLC

26 March 2010

 



TR-1:  notification of major interests in shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:	Allergy Therapeutics plc
2. Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other : Increase in total voting rights issued by the Company		X
3. Full name of person(s) subject to the notification obligation:	FIL Limited
4. Full name of shareholder(s) (if different from 3.):	FISL JP Morgan, Bournemouth nominee FIL Limited is the parent holding company for various direct and indirect subsidiaries including FIL Fund Management Limited, FIL Investment Services Limited, FIL Gestion, FIL Asset Management (Korea) Limited FIL Investment Management (Hong Kong) Limited, FIL Pension Management, Fidelity Investments Japan and FIL Investments International, investment managers for various non-US investment companies and institutional clients
5. Date of the transaction and date on which the threshold is crossed or reached:	24 March 2010
6. Date on which issuer notified:	25 March 2010
7. Threshold(s) that is/are crossed or reached:                  Above 5%

8. Notified details
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the Triggering transaction		Resulting situation after the triggering transaction
	Number of Shares	Number of Voting Rights	Number of shares	Number of voting rights		% of voting rights
			Direct	Direct	Indirect	Direct	Indirect
GB00B02LCQ05	15,117,776 15,117,776		15,117,776	15,117,776			4.88%

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/ Conversion  Period/ Date	Number of voting rights that may be acquired if the instrument is exercised/ converted	% of voting rights
N/A	N/A	N/A	N/A	N/A

Total (A+B)
Number of voting rights	% of voting rights
15,117,776	4.88%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

See 4 above

Proxy Voting:
10. Name of the proxy holder:	FIL Limited
11. Number of voting rights proxy holder will cease to hold:	N/A
12. Date on which proxy holder will cease to hold voting rights:	N/A

13. Additional information:	Increase in total voting rights issued by the company
14. Contact name	Amanda Chana
15. Contact telephone number	[e-mail]

 

END

 

 

HOLUNAKRROAOURR